249 related articles for article (PubMed ID: 29768676)
1. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.
Jørgensen AS; Adogamhe PE; Laufer JM; Legler DF; Veldkamp CT; Rosenkilde MM; Hjortø GM
J Leukoc Biol; 2018 Aug; 104(2):401-411. PubMed ID: 29768676
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
Haessler U; Pisano M; Wu M; Swartz MA
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
[TBL] [Abstract][Full Text] [Related]
3. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
Front Immunol; 2019; 10():2156. PubMed ID: 31572374
[TBL] [Abstract][Full Text] [Related]
4. Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21.
Moussouras NA; Hjortø GM; Peterson FC; Szpakowska M; Chevigné A; Rosenkilde MM; Volkman BF; Dwinell MB
Biochemistry; 2020 Apr; 59(13):1338-1350. PubMed ID: 32182428
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM
Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443
[TBL] [Abstract][Full Text] [Related]
6. CCL19/CCL21-Dependent Chemotaxis of Dendritic Cells in Healthy Individuals and Patients with Brain Tumors.
Tyrinova TV; Leplina OY; Tikhonova MA; Mishinov SV; Stupak VV; Ostanin AA; Chernykh ER
Bull Exp Biol Med; 2015 Apr; 158(6):785-8. PubMed ID: 25894778
[TBL] [Abstract][Full Text] [Related]
7. Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines.
Hjortø GM; Larsen O; Steen A; Daugvilaite V; Berg C; Fares S; Hansen M; Ali S; Rosenkilde MM
Front Immunol; 2016; 7():568. PubMed ID: 28018341
[TBL] [Abstract][Full Text] [Related]
8. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
[TBL] [Abstract][Full Text] [Related]
9. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.
Jørgensen AS; Rosenkilde MM; Hjortø GM
Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053
[TBL] [Abstract][Full Text] [Related]
10. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
11. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
[TBL] [Abstract][Full Text] [Related]
12. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
[TBL] [Abstract][Full Text] [Related]
13. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
Hauser MA; Legler DF
J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
[TBL] [Abstract][Full Text] [Related]
14. Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.
Hansen M; Met Ö; Larsen NB; Rosenkilde MM; Andersen MH; Svane IM; Hjortø GM
Cytotherapy; 2016 Sep; 18(9):1187-96. PubMed ID: 27424146
[TBL] [Abstract][Full Text] [Related]
15. Elevated concentrations of CCR7 ligands in patients with eosinophilic pneumonia.
Nureki S; Miyazaki E; Ishi T; Ito T; Takenaka R; Ando M; Kumamoto T
Allergy; 2013 Nov; 68(11):1387-95. PubMed ID: 24111618
[TBL] [Abstract][Full Text] [Related]
16. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.
Barmore AJ; Castex SM; Gouletas BA; Griffith AJ; Metz SW; Muelder NG; Populin MJ; Sackett DM; Schuster AM; Veldkamp CT
Biochem Biophys Res Commun; 2016 Sep; 477(4):602-606. PubMed ID: 27338641
[TBL] [Abstract][Full Text] [Related]
17. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2.
Scandella E; Men Y; Legler DF; Gillessen S; Prikler L; Ludewig B; Groettrup M
Blood; 2004 Mar; 103(5):1595-601. PubMed ID: 14592837
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19.
Ott TR; Lio FM; Olshefski D; Liu XJ; Ling N; Struthers RS
Biochem Biophys Res Commun; 2006 Sep; 348(3):1089-93. PubMed ID: 16904643
[TBL] [Abstract][Full Text] [Related]
19. Differential ligand-signaling network of CCL19/CCL21-CCR7 system.
Raju R; Gadakh S; Gopal P; George B; Advani J; Soman S; Prasad TS; Girijadevi R
Database (Oxford); 2015; 2015():. PubMed ID: 26504105
[TBL] [Abstract][Full Text] [Related]
20. Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses.
Hauser MA; Kindinger I; Laufer JM; Späte AK; Bucher D; Vanes SL; Krueger WA; Wittmann V; Legler DF
J Leukoc Biol; 2016 Jun; 99(6):993-1007. PubMed ID: 26819318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
